RU2011152319A - COMPOSITIONS OR MEDICATIONS OF ANTIMO-MICROBIAL AND RELATIVE ANTIMO-MICROBIAL COMPOUNDS Possessing a High Penetrating Ability - Google Patents
COMPOSITIONS OR MEDICATIONS OF ANTIMO-MICROBIAL AND RELATIVE ANTIMO-MICROBIAL COMPOUNDS Possessing a High Penetrating Ability Download PDFInfo
- Publication number
- RU2011152319A RU2011152319A RU2011152319/04A RU2011152319A RU2011152319A RU 2011152319 A RU2011152319 A RU 2011152319A RU 2011152319/04 A RU2011152319/04 A RU 2011152319/04A RU 2011152319 A RU2011152319 A RU 2011152319A RU 2011152319 A RU2011152319 A RU 2011152319A
- Authority
- RU
- Russia
- Prior art keywords
- structures
- substituted
- unsubstituted
- group
- acid
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims 29
- 230000000149 penetrating Effects 0.000 title claims 10
- 150000001875 compounds Chemical class 0.000 title claims 5
- 239000003814 drug Substances 0.000 title claims 2
- 125000000217 alkyl group Chemical group 0.000 claims 23
- 125000003118 aryl group Chemical group 0.000 claims 23
- 125000001072 heteroaryl group Chemical group 0.000 claims 23
- 125000000753 cycloalkyl group Chemical group 0.000 claims 21
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 20
- 229910052739 hydrogen Inorganic materials 0.000 claims 18
- 229910052760 oxygen Inorganic materials 0.000 claims 18
- 229910052717 sulfur Inorganic materials 0.000 claims 17
- 125000003545 alkoxy group Chemical group 0.000 claims 15
- 125000005010 perfluoroalkyl group Chemical group 0.000 claims 14
- 150000001350 alkyl halides Chemical class 0.000 claims 12
- 229910052799 carbon Inorganic materials 0.000 claims 12
- 125000003282 alkyl amino group Chemical group 0.000 claims 11
- 125000000304 alkynyl group Chemical group 0.000 claims 11
- 125000003342 alkenyl group Chemical group 0.000 claims 10
- 239000003782 beta lactam antibiotic agent Substances 0.000 claims 10
- 239000002132 β-lactam antibiotic Substances 0.000 claims 10
- 239000002253 acid Substances 0.000 claims 9
- 239000004599 antimicrobial Substances 0.000 claims 9
- -1 phosphate oxime Chemical class 0.000 claims 9
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 8
- 125000004414 alkyl thio group Chemical group 0.000 claims 8
- 229910052698 phosphorus Inorganic materials 0.000 claims 8
- 230000000845 anti-microbial Effects 0.000 claims 7
- 125000004432 carbon atoms Chemical group C* 0.000 claims 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims 6
- 201000009910 diseases by infectious agent Diseases 0.000 claims 6
- BDAGIHXWWSANSR-UHFFFAOYSA-N formic acid Chemical compound OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims 6
- 125000004435 hydrogen atoms Chemical group [H]* 0.000 claims 6
- 230000035515 penetration Effects 0.000 claims 6
- GVNVAWHJIKLAGL-UHFFFAOYSA-N 2-(cyclohexen-1-yl)cyclohexan-1-one Chemical compound O=C1CCCCC1C1=CCCCC1 GVNVAWHJIKLAGL-UHFFFAOYSA-N 0.000 claims 5
- 102100000129 CHURC1 Human genes 0.000 claims 5
- 101710014631 CHURC1 Proteins 0.000 claims 5
- 229910052757 nitrogen Inorganic materials 0.000 claims 5
- 239000008194 pharmaceutical composition Substances 0.000 claims 5
- VZCYOOQTPOCHFL-OWOJBTEDSA-N (E)-but-2-enedioate;hydron Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 claims 4
- WPYMKLBDIGXBTP-UHFFFAOYSA-N Benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims 4
- WXTMDXOMEHJXQO-UHFFFAOYSA-N Gentisic acid Chemical compound OC(=O)C1=CC(O)=CC=C1O WXTMDXOMEHJXQO-UHFFFAOYSA-N 0.000 claims 4
- RGHNJXZEOKUKBD-SQOUGZDYSA-N Gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 claims 4
- JOXIMZWYDAKGHI-UHFFFAOYSA-N P-Toluenesulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N Salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims 4
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims 4
- 125000004122 cyclic group Chemical group 0.000 claims 4
- 125000005647 linker group Chemical group 0.000 claims 4
- AFVFQIVMOAPDHO-UHFFFAOYSA-N methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 claims 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims 4
- ABLZXFCXXLZCGV-UHFFFAOYSA-N phosphorous acid Chemical compound OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 4
- 239000011780 sodium chloride Substances 0.000 claims 4
- 239000000126 substance Substances 0.000 claims 4
- 206010035664 Pneumonia Diseases 0.000 claims 3
- 206010040047 Sepsis Diseases 0.000 claims 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims 3
- 125000004448 alkyl carbonyl group Chemical group 0.000 claims 3
- 125000003277 amino group Chemical group 0.000 claims 3
- 239000003937 drug carrier Substances 0.000 claims 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims 3
- 101700082223 how Proteins 0.000 claims 3
- 229920000728 polyester Polymers 0.000 claims 3
- 229960000583 Acetic Acid Drugs 0.000 claims 2
- SRSXLGNVWSONIS-UHFFFAOYSA-N Benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 claims 2
- 239000005711 Benzoic acid Substances 0.000 claims 2
- 210000001072 Colon Anatomy 0.000 claims 2
- 229960002598 Fumaric acid Drugs 0.000 claims 2
- 229940097043 Glucuronic Acid Drugs 0.000 claims 2
- 229960002989 Glutamic Acid Drugs 0.000 claims 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 2
- TWBYWOBDOCUKOW-UHFFFAOYSA-N Isonicotinic acid Chemical compound OC(=O)C1=CC=NC=C1 TWBYWOBDOCUKOW-UHFFFAOYSA-N 0.000 claims 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims 2
- 229960000448 Lactic acid Drugs 0.000 claims 2
- FEWJPZIEWOKRBE-XIXRPRMCSA-N Mesotartaric acid Chemical compound OC(=O)[C@@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-XIXRPRMCSA-N 0.000 claims 2
- 229940055726 Pantothenic Acid Drugs 0.000 claims 2
- 206010035148 Plague Diseases 0.000 claims 2
- 210000000664 Rectum Anatomy 0.000 claims 2
- 206010057190 Respiratory tract infection Diseases 0.000 claims 2
- 206010039447 Salmonellosis Diseases 0.000 claims 2
- 210000002784 Stomach Anatomy 0.000 claims 2
- 229960005137 Succinic Acid Drugs 0.000 claims 2
- 241000700605 Viruses Species 0.000 claims 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Vitamin C Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims 2
- 241000607479 Yersinia pestis Species 0.000 claims 2
- 230000001154 acute Effects 0.000 claims 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims 2
- 235000010323 ascorbic acid Nutrition 0.000 claims 2
- 239000011668 ascorbic acid Substances 0.000 claims 2
- 229960005070 ascorbic acid Drugs 0.000 claims 2
- 230000001580 bacterial Effects 0.000 claims 2
- 229940092714 benzenesulfonic acid Drugs 0.000 claims 2
- 235000010233 benzoic acid Nutrition 0.000 claims 2
- 229960004365 benzoic acid Drugs 0.000 claims 2
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 claims 2
- 229960002079 calcium pantothenate Drugs 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 229960004106 citric acid Drugs 0.000 claims 2
- 238000003776 cleavage reaction Methods 0.000 claims 2
- 150000002148 esters Chemical class 0.000 claims 2
- CCIVGXIOQKPBKL-UHFFFAOYSA-N ethanesulfonic acid Chemical compound CCS(O)(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-N 0.000 claims 2
- 235000019253 formic acid Nutrition 0.000 claims 2
- 229940013688 formic acid Drugs 0.000 claims 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N fumaric acid Chemical compound OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims 2
- 239000001530 fumaric acid Substances 0.000 claims 2
- 229960005219 gentisic acid Drugs 0.000 claims 2
- 239000000174 gluconic acid Substances 0.000 claims 2
- 229950006191 gluconic acid Drugs 0.000 claims 2
- 235000012208 gluconic acid Nutrition 0.000 claims 2
- 239000004220 glutamic acid Substances 0.000 claims 2
- 235000013922 glutamic acid Nutrition 0.000 claims 2
- CPELXLSAUQHCOX-UHFFFAOYSA-N hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 claims 2
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 claims 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims 2
- 239000004310 lactic acid Substances 0.000 claims 2
- 235000014655 lactic acid Nutrition 0.000 claims 2
- 230000004807 localization Effects 0.000 claims 2
- 239000011976 maleic acid Substances 0.000 claims 2
- 229940098895 maleic acid Drugs 0.000 claims 2
- 201000009906 meningitis Diseases 0.000 claims 2
- 229940098779 methanesulfonic acid Drugs 0.000 claims 2
- 244000005700 microbiome Species 0.000 claims 2
- GRYLNZFGIOXLOG-UHFFFAOYSA-N nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 claims 2
- 239000011713 pantothenic acid Substances 0.000 claims 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N pantothenic acid Natural products OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims 2
- 235000019161 pantothenic acid Nutrition 0.000 claims 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 2
- 239000010452 phosphate Substances 0.000 claims 2
- 229960004889 salicylic acid Drugs 0.000 claims 2
- 239000001384 succinic acid Substances 0.000 claims 2
- 239000011975 tartaric acid Substances 0.000 claims 2
- 229960001367 tartaric acid Drugs 0.000 claims 2
- 235000002906 tartaric acid Nutrition 0.000 claims 2
- MNFORVFSTILPAW-UHFFFAOYSA-N Β-Lactam Chemical class O=C1CCN1 MNFORVFSTILPAW-UHFFFAOYSA-N 0.000 claims 2
- AEMOLEFTQBMNLQ-QIUUJYRFSA-N β-D-glucuronic acid Chemical compound O[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-QIUUJYRFSA-N 0.000 claims 2
- 206010000565 Acquired immunodeficiency syndrome Diseases 0.000 claims 1
- 208000000230 African Trypanosomiasis Diseases 0.000 claims 1
- 206010003246 Arthritis Diseases 0.000 claims 1
- 206010003486 Aspergillus infection Diseases 0.000 claims 1
- 241000193738 Bacillus anthracis Species 0.000 claims 1
- 241000894006 Bacteria Species 0.000 claims 1
- 206010005098 Blastomycosis Diseases 0.000 claims 1
- 210000004556 Brain Anatomy 0.000 claims 1
- 206010006451 Bronchitis Diseases 0.000 claims 1
- 206010006500 Brucellosis Diseases 0.000 claims 1
- 241000222122 Candida albicans Species 0.000 claims 1
- 206010007134 Candida infection Diseases 0.000 claims 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate dianion Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims 1
- 206010008631 Cholera Diseases 0.000 claims 1
- 206010009657 Clostridium difficile colitis Diseases 0.000 claims 1
- 108010065152 Coagulase Proteins 0.000 claims 1
- 241000223205 Coccidioides immitis Species 0.000 claims 1
- 206010010741 Conjunctivitis Diseases 0.000 claims 1
- 206010012735 Diarrhoea Diseases 0.000 claims 1
- 206010013023 Diphtheria Diseases 0.000 claims 1
- 210000001198 Duodenum Anatomy 0.000 claims 1
- 208000004145 Endometritis Diseases 0.000 claims 1
- 208000004232 Enteritis Diseases 0.000 claims 1
- 208000010227 Enterocolitis Diseases 0.000 claims 1
- 206010014896 Enterocolitis haemorrhagic Diseases 0.000 claims 1
- 210000001508 Eye Anatomy 0.000 claims 1
- 206010016952 Food poisoning Diseases 0.000 claims 1
- 241000233866 Fungi Species 0.000 claims 1
- 210000000232 Gallbladder Anatomy 0.000 claims 1
- 208000005577 Gastroenteritis Diseases 0.000 claims 1
- 206010017931 Gastrointestinal anthrax Diseases 0.000 claims 1
- 210000002216 Heart Anatomy 0.000 claims 1
- 208000006572 Human Influenza Diseases 0.000 claims 1
- 206010021531 Impetigo Diseases 0.000 claims 1
- 206010022000 Influenza Diseases 0.000 claims 1
- 208000009449 Inhalation anthrax Diseases 0.000 claims 1
- 210000000936 Intestines Anatomy 0.000 claims 1
- 210000003734 Kidney Anatomy 0.000 claims 1
- 208000007764 Legionnaires' Disease Diseases 0.000 claims 1
- 206010024229 Leprosy Diseases 0.000 claims 1
- 206010024238 Leptospirosis Diseases 0.000 claims 1
- 206010024641 Listeriosis Diseases 0.000 claims 1
- 210000004185 Liver Anatomy 0.000 claims 1
- 210000004072 Lung Anatomy 0.000 claims 1
- 206010025169 Lyme disease Diseases 0.000 claims 1
- 206010027274 Meningococcal infection Diseases 0.000 claims 1
- 230000036740 Metabolism Effects 0.000 claims 1
- 210000000214 Mouth Anatomy 0.000 claims 1
- 241000204031 Mycoplasma Species 0.000 claims 1
- 206010028885 Necrotising fasciitis Diseases 0.000 claims 1
- 208000005119 Necrotizing Pneumonia Diseases 0.000 claims 1
- 210000001331 Nose Anatomy 0.000 claims 1
- 206010029803 Nosocomial infection Diseases 0.000 claims 1
- 206010033078 Otitis media Diseases 0.000 claims 1
- 239000004936 P-84 Substances 0.000 claims 1
- 210000000496 Pancreas Anatomy 0.000 claims 1
- 206010049752 Peau d'orange Diseases 0.000 claims 1
- 208000008469 Peptic Ulcer Diseases 0.000 claims 1
- 206010034839 Pharyngitis streptococcal Diseases 0.000 claims 1
- 206010035667 Pneumonia anthrax Diseases 0.000 claims 1
- 206010035718 Pneumonia legionella Diseases 0.000 claims 1
- 206010054161 Pontiac fever Diseases 0.000 claims 1
- 208000003251 Pruritus Diseases 0.000 claims 1
- 206010037128 Pseudomembranous colitis Diseases 0.000 claims 1
- 206010061471 Pseudomonas infection Diseases 0.000 claims 1
- 206010037151 Psittacosis Diseases 0.000 claims 1
- 206010037660 Pyrexia Diseases 0.000 claims 1
- 206010039207 Rocky mountain spotted fever Diseases 0.000 claims 1
- 206010039587 Scarlet fever Diseases 0.000 claims 1
- 206010040550 Shigella infection Diseases 0.000 claims 1
- 206010040872 Skin infection Diseases 0.000 claims 1
- 206010041736 Sporotrichosis Diseases 0.000 claims 1
- 208000006379 Syphilis Diseases 0.000 claims 1
- 208000002474 Tinea Diseases 0.000 claims 1
- 210000002105 Tongue Anatomy 0.000 claims 1
- 231100000765 Toxin Toxicity 0.000 claims 1
- 206010044325 Trachoma Diseases 0.000 claims 1
- 241000390203 Trachoma Species 0.000 claims 1
- 241000893966 Trichophyton verrucosum Species 0.000 claims 1
- 206010045146 Tularaemia Diseases 0.000 claims 1
- 206010068760 Ulcers Diseases 0.000 claims 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 claims 1
- 208000000143 Urethritis Diseases 0.000 claims 1
- 210000001635 Urinary Tract Anatomy 0.000 claims 1
- 210000003462 Veins Anatomy 0.000 claims 1
- 208000001877 Whooping Cough Diseases 0.000 claims 1
- 208000003152 Yellow Fever Diseases 0.000 claims 1
- 206010061418 Zygomycosis Diseases 0.000 claims 1
- 125000003158 alcohol group Chemical group 0.000 claims 1
- 150000001408 amides Chemical class 0.000 claims 1
- 235000001014 amino acid Nutrition 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 claims 1
- 239000007864 aqueous solution Substances 0.000 claims 1
- 201000002909 aspergillosis Diseases 0.000 claims 1
- 201000006824 bubonic plague Diseases 0.000 claims 1
- 201000003984 candidiasis Diseases 0.000 claims 1
- KXDHJXZQYSOELW-UHFFFAOYSA-M carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 claims 1
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 claims 1
- 230000036232 cellulite Effects 0.000 claims 1
- 235000015165 citric acid Nutrition 0.000 claims 1
- 201000003486 coccidioidomycosis Diseases 0.000 claims 1
- 201000007336 cryptococcosis Diseases 0.000 claims 1
- 201000004836 cutaneous anthrax Diseases 0.000 claims 1
- 125000000000 cycloalkoxy group Chemical group 0.000 claims 1
- 201000003146 cystitis Diseases 0.000 claims 1
- 201000008286 diarrhea Diseases 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 229940079593 drugs Drugs 0.000 claims 1
- 201000000297 erysipelas Diseases 0.000 claims 1
- 201000000628 gas gangrene Diseases 0.000 claims 1
- 201000001066 hemolytic-uremic syndrome Diseases 0.000 claims 1
- 201000002563 histoplasmosis Diseases 0.000 claims 1
- 150000002466 imines Chemical class 0.000 claims 1
- 201000007119 infective endocarditis Diseases 0.000 claims 1
- 201000004792 malaria Diseases 0.000 claims 1
- 230000004060 metabolic process Effects 0.000 claims 1
- 230000035786 metabolism Effects 0.000 claims 1
- 201000007524 mucormycosis Diseases 0.000 claims 1
- 201000007970 necrotizing fasciitis Diseases 0.000 claims 1
- 244000039328 opportunistic pathogens Species 0.000 claims 1
- 210000000056 organs Anatomy 0.000 claims 1
- 201000000901 ornithosis Diseases 0.000 claims 1
- 201000005702 pertussis Diseases 0.000 claims 1
- 150000003141 primary amines Chemical group 0.000 claims 1
- 230000002685 pulmonary Effects 0.000 claims 1
- 210000002345 respiratory system Anatomy 0.000 claims 1
- 201000003068 rheumatic fever Diseases 0.000 claims 1
- 125000000467 secondary amino group Chemical group [H]N([*:1])[*:2] 0.000 claims 1
- 201000005113 shigellosis Diseases 0.000 claims 1
- 201000009890 sinusitis Diseases 0.000 claims 1
- 201000002612 sleeping sickness Diseases 0.000 claims 1
- 201000010874 syndrome Diseases 0.000 claims 1
- 125000001302 tertiary amino group Chemical group 0.000 claims 1
- 150000007970 thio esters Chemical class 0.000 claims 1
- 150000003568 thioethers Chemical class 0.000 claims 1
- 239000003053 toxin Substances 0.000 claims 1
- 201000005485 toxoplasmosis Diseases 0.000 claims 1
- 201000008827 tuberculosis Diseases 0.000 claims 1
- 201000008297 typhoid fever Diseases 0.000 claims 1
- 231100000397 ulcer Toxicity 0.000 claims 1
- 230000002792 vascular Effects 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
- HJRVTULLGWTJDM-AKGZTFGVSA-N CC1NCS[C@H]1C Chemical compound CC1NCS[C@H]1C HJRVTULLGWTJDM-AKGZTFGVSA-N 0.000 description 1
Claims (28)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200910141944.X | 2009-06-10 | ||
US12/482,373 US20100040548A1 (en) | 2006-12-10 | 2009-06-10 | High penetration prodrug compositions of antimicrobials and antimicrobial-related compounds |
CN200910141944 | 2009-06-10 | ||
US12/482,373 | 2009-06-10 | ||
PCT/CN2010/073743 WO2010142241A1 (en) | 2009-06-10 | 2010-06-10 | High penetration compositions or prodrugs of antimicrobials and antimicrobial-related compounds |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2016115906A Division RU2016115906A (en) | 2009-06-10 | 2010-06-10 | COMPOSITIONS OR MEDICATIONS OF ANTIMO-MICROBIAL AND RELATIVE ANTIMO-MICROBIAL COMPOUNDS Possessing a High Penetrating Ability |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2011152319A true RU2011152319A (en) | 2013-07-20 |
RU2586287C2 RU2586287C2 (en) | 2016-06-10 |
Family
ID=43308429
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2011152319/15A RU2586287C2 (en) | 2009-06-10 | 2010-06-10 | High penetration compositions or prodrugs of antimicrobials and antimicrobial-related compounds |
RU2016115906A RU2016115906A (en) | 2009-06-10 | 2010-06-10 | COMPOSITIONS OR MEDICATIONS OF ANTIMO-MICROBIAL AND RELATIVE ANTIMO-MICROBIAL COMPOUNDS Possessing a High Penetrating Ability |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2016115906A RU2016115906A (en) | 2009-06-10 | 2010-06-10 | COMPOSITIONS OR MEDICATIONS OF ANTIMO-MICROBIAL AND RELATIVE ANTIMO-MICROBIAL COMPOUNDS Possessing a High Penetrating Ability |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP2440523A4 (en) |
JP (3) | JP5916129B2 (en) |
KR (2) | KR20120034721A (en) |
CN (1) | CN105566213B (en) |
AU (2) | AU2010257905B2 (en) |
BR (1) | BRPI1012905A8 (en) |
CA (1) | CA2764376C (en) |
HK (2) | HK1178537A1 (en) |
MX (2) | MX366035B (en) |
RU (2) | RU2586287C2 (en) |
WO (1) | WO2010142241A1 (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EA028342B1 (en) | 2011-09-09 | 2017-11-30 | Мерк Шарп И Доум Корп. | Methods for treating pneumonia |
CA3189252A1 (en) | 2012-05-16 | 2013-11-21 | Techfields Pharma Co., Ltd. | High penetration prodrug compositions and pharmaceutical composition thereof for treatment of pulmonary conditions |
US8809314B1 (en) | 2012-09-07 | 2014-08-19 | Cubist Pharmacueticals, Inc. | Cephalosporin compound |
US8476425B1 (en) | 2012-09-27 | 2013-07-02 | Cubist Pharmaceuticals, Inc. | Tazobactam arginine compositions |
US9872906B2 (en) | 2013-03-15 | 2018-01-23 | Merck Sharp & Dohme Corp. | Ceftolozane antibiotic compositions |
CA3212170A1 (en) * | 2013-03-15 | 2014-09-18 | Techfields Pharma Co., Ltd. | Novel high penetration drugs and their compositions thereof for treatment of parkinson diseases |
AU2014227660B2 (en) | 2013-03-15 | 2014-11-06 | Merck Sharp & Dohme Llc | Ceftolozane antibiotic compositions |
US20140274991A1 (en) | 2013-03-15 | 2014-09-18 | Cubist Pharmaceuticals, Inc. | Ceftolozane pharmaceutical compositions |
WO2015035376A2 (en) | 2013-09-09 | 2015-03-12 | Calixa Therapeutics, Inc. | Treating infections with ceftolozane/tazobactam in subjects having impaired renal function |
US20150094293A1 (en) | 2013-09-27 | 2015-04-02 | Calixa Therapeutics, Inc. | Solid forms of ceftolozane |
CN108396007B (en) * | 2018-03-15 | 2021-07-23 | 东北农业大学 | Method for in-vitro construction of three-dimensional model of blood and milk barrier of dairy cow |
WO2023134733A1 (en) * | 2022-01-17 | 2023-07-20 | Techfields Pharma Co., Ltd. | Treatment of signs, symptoms and/or complications of viral, bacterial, protozoal, and/or fungal infections by high penetration prodrugs |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2694031A (en) * | 1949-07-07 | 1954-11-09 | Leo Pharm Prod Ltd | Hydroiodides of amino esters of penicillin and oil composition thereof |
BE790440A (en) * | 1971-10-23 | 1973-04-24 | Bayer Ag | |
IT1048274B (en) * | 1974-03-02 | 1980-11-20 | Farmaceutici Italia | Acylamido-methyl penicillin and cephalosporin esters - for oral administration and subsequent in-tissue enzymic hydrolysis to parent antibiotic |
GB1569421A (en) * | 1976-06-11 | 1980-06-18 | Beecham Group Ltd | Penicillin compositions |
GB1578730A (en) * | 1976-06-24 | 1980-11-05 | Beecham Group Ltd | Esters of penicillin antibiotics |
JPS5377083A (en) * | 1976-12-16 | 1978-07-08 | Asahi Chem Ind Co Ltd | Penicillins and their derivatives |
US4215120A (en) * | 1977-07-14 | 1980-07-29 | Beecham Group Limited | Penicillin esters and their preparation |
JPS5446800A (en) * | 1977-09-22 | 1979-04-12 | Sangyo Kagaku Kenkyu Kyokai | Antibacterial compound |
JPS5646885A (en) * | 1979-09-27 | 1981-04-28 | Meiji Seika Kaisha Ltd | Novel cephamycin ester and its preparation |
US4428935A (en) * | 1982-05-24 | 1984-01-31 | Pfizer Inc. | Penicillanic acid dioxide prodrug |
DE4423915A1 (en) * | 1994-07-07 | 1996-01-11 | Carl Heinrich Dr Weischer | New tocopheryl esters of sulphasalazine or 5-amino-salicyclic acid |
ATE229805T1 (en) * | 1996-05-10 | 2003-01-15 | Upjohn Co | TOPICAL ADMINISTRATION OF PREMAFLOXACIN FOR THE TREATMENT OF SYSTEMIC BACTERIAL DISEASES |
US5929086A (en) * | 1996-05-10 | 1999-07-27 | Pharmacia & Upjohn Company | Topical administration of antimicrobial agents for the treatment of systemic bacterial diseases |
EP1792882A1 (en) * | 2005-12-02 | 2007-06-06 | SOLVAY (Société Anonyme) | Process for the manufacture of lightweight construction materials containing clay. |
CA2671938C (en) * | 2006-12-10 | 2017-10-17 | Chongxi Yu | Transdermal delivery systems of beta-lactam antibiotics |
WO2010028458A1 (en) * | 2008-09-12 | 2010-03-18 | Parnell Laboratories (Aust) Pty Ltd | Prodrugs of isoxazolyl penicillins and uses thereof |
MX362949B (en) * | 2008-12-04 | 2019-02-27 | Yu Chongxi | High penetration compositions and their applications. |
-
2010
- 2010-06-10 RU RU2011152319/15A patent/RU2586287C2/en not_active IP Right Cessation
- 2010-06-10 WO PCT/CN2010/073743 patent/WO2010142241A1/en active Application Filing
- 2010-06-10 KR KR1020127000567A patent/KR20120034721A/en active Application Filing
- 2010-06-10 KR KR1020177035075A patent/KR102102972B1/en active IP Right Grant
- 2010-06-10 CN CN201610005542.7A patent/CN105566213B/en active Active
- 2010-06-10 BR BRPI1012905A patent/BRPI1012905A8/en not_active Application Discontinuation
- 2010-06-10 MX MX2015003152A patent/MX366035B/en unknown
- 2010-06-10 RU RU2016115906A patent/RU2016115906A/en not_active Application Discontinuation
- 2010-06-10 EP EP10785754.2A patent/EP2440523A4/en not_active Withdrawn
- 2010-06-10 MX MX2011013314A patent/MX338552B/en active IP Right Grant
- 2010-06-10 AU AU2010257905A patent/AU2010257905B2/en not_active Ceased
- 2010-06-10 JP JP2012514336A patent/JP5916129B2/en active Active
- 2010-06-10 CA CA2764376A patent/CA2764376C/en active Active
-
2013
- 2013-05-27 HK HK13106282.9A patent/HK1178537A1/en unknown
-
2015
- 2015-06-02 JP JP2015112700A patent/JP6256924B2/en active Active
-
2016
- 2016-06-23 HK HK16107313.7A patent/HK1219275A1/en unknown
-
2017
- 2017-02-09 AU AU2017200897A patent/AU2017200897B2/en not_active Ceased
- 2017-11-28 JP JP2017228121A patent/JP6707512B2/en active Active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2011152319A (en) | COMPOSITIONS OR MEDICATIONS OF ANTIMO-MICROBIAL AND RELATIVE ANTIMO-MICROBIAL COMPOUNDS Possessing a High Penetrating Ability | |
RU2016115906A (en) | COMPOSITIONS OR MEDICATIONS OF ANTIMO-MICROBIAL AND RELATIVE ANTIMO-MICROBIAL COMPOUNDS Possessing a High Penetrating Ability | |
JP2012529443A5 (en) | ||
JP5324463B2 (en) | Transdermal delivery system for β-lactam antibiotics | |
RU2015117533A (en) | HYDROGEL-BASED MEDICINES | |
HRP20191586T1 (en) | Protein-active agent conjugates and method for preparing the same | |
CA2245680C (en) | Method of detection of influenza virus and compounds for use therein | |
ES2286278T3 (en) | MULTIDENTED AZA LIGANDS THAT CAN BE COMPLEXED WITH METAL IONS AND USE OF THEM IN DIAGNOSTICS AND THERAPY. | |
AU2006216669A1 (en) | Compositions and methods for targeted delivery of immune response modifiers | |
US20230130980A1 (en) | High penetration prodrug compositions of antimicrobials and antimicrobial-related compounds | |
Smith et al. | The response of the popliteal lymph node of the sheep to swine influenza virus | |
CN102936338B (en) | Cationic lipoid plastid and preparation method thereof | |
EP0869801B1 (en) | Therapeutic and diagnostic agents for the treatment of microbial infections | |
NZ523932A (en) | Use of metal complexes containing perfluoroalkyl as contrast agents in MR-imaging for the representation of plaques, tumours and necroses | |
BASMADJIAN et al. | Generation of polyclonal catalytic antibodies against cocaine using transition state analogs of cocaine conjugated to diphtheria toxoid | |
IL305355A (en) | Tlr7 and tlr8 agonists for the treatment of cancer and/or infectious diseases | |
US20040247611A1 (en) | Identification of pathogen-ligand interactions | |
IL296927A (en) | Antiviral compounds and method for treating rna viral infection, particularly covid-19 | |
CN116115768A (en) | Antibacterial agent and preparation method and application thereof | |
AU706810B2 (en) | Method of detection of influenza virus and compounds for use therein | |
ES2396169T3 (en) | Process for the preparation of haptens based on nicotine | |
CN116407520A (en) | Bionic vaccine oral delivery system and preparation method and application thereof | |
Morgan | Dendritic supramolecular assemblies |